Daratumumab-based regimen for cold agglutinin disease refractory to therapy directing B-cell clone

Leuk Lymphoma. 2024 Mar;65(3):410-412. doi: 10.1080/10428194.2023.2287963. Epub 2023 Nov 29.

Authors

Kai-Ni Shen¹, Dan-Qing Zhao¹, Yue-Ying Mao¹, Hua-Cong Cai¹, Jian Li¹, Xin-Xin Cao¹

Affiliation

¹ Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

PMID: 38018808
DOI: 10.1080/10428194.2023.2287963

No abstract available

MeSH terms

Anemia, Hemolytic, Autoimmune* / diagnosis
Anemia, Hemolytic, Autoimmune* / drug therapy
Antibodies, Monoclonal / adverse effects
B-Lymphocytes
Clone Cells
Humans
Multiple Myeloma* / therapy

Substances

daratumumab
Antibodies, Monoclonal